ArticleKidney medicine2026
Triple-Positive Serology in Rapidly Progressive Glomerulonephritis: A Diagnostic Dilemma.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The acute onset of malignant hypertension and acute kidney injury in patients with features suggestive of systemic sclerosis often raises concern for scleroderma renal crisis, a life-threatening complication requiring prompt recognition and angiotensin-converting enzyme inhibitor therapy. However, other autoimmune vasculitides, including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and antiglomerular basement membrane (anti-GBM) disease, can present similarly but require immunosuppressive therapy. We reported a diagnostically challenging case of a 72-year-old woman with interstitial lung disease, Raynaud's phenomenon, and serologic findings of antitopoisomerase I antibody and antimyeloperoxidase (p-ANCA) antibodies. Given this clinical picture, scleroderma renal crisis was initially suspected. However, a kidney biopsy revealed pauci-immune necrotizing and crescentic glomerulonephritis with uniform crescents and without linear IgG deposition along the GBM. Given the uniformity of crescents, additional serologic testing revealed elevated anti-GBM antibody levels, posing a therapeutic dilemma regarding the presence of clinically significant anti-GBM disease in the absence of immunofluorescence confirmation. This case highlighted the critical role of early kidney biopsy in ambiguous presentations and the need for heightened awareness of overlapping autoimmune syndromes to guide timely and appropriate treatment. Systematic reporting of such overlap syndromes is essential for improving diagnostic accuracy and optimizing outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.